Stock Events

Stock Events

Biogen 

$189.13
480
+$1.92+1.03% Tuesday 20:00

Statistics

Day High
189.69
Day Low
186
52W High
201.18
52W Low
116.82
Volume
453,046
Avg. Volume
-
Mkt Cap
27.76B
P/E Ratio
20.11
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.63
2.91
4.19
5.47
Expected EPS
3.331419
Actual EPS
N/A

Financials

13.07%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
19.78BRevenue
2.59BNet Income

Analyst Ratings

216.67Average Price Target
The highest estimate is 275.00.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
53%
Hold
40%
Sell
7%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIIB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes directly with Biogen in the multiple sclerosis and spinal muscular atrophy markets.
Novartis
NVS
Mkt Cap279.67B
Novartis AG competes in the multiple sclerosis space with its drug Gilenya and in gene therapy for spinal muscular atrophy.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. has a broad portfolio that includes treatments in areas where Biogen is active, such as neurological disorders.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. competes in the area of neurodegenerative diseases, a key focus area for Biogen.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company is involved in Alzheimer's disease research and competes with Biogen's portfolio in neurodegenerative diseases.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. has a growing portfolio in neuroscience, directly competing with Biogen's core market.
AMGEN
AMGN
Mkt Cap178B
Amgen Inc. competes with Biogen in the broader biotech space, including treatments for neurological conditions.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences, Inc. is expanding into the immunology and inflammatory disease market, areas of interest for Biogen.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries Limited offers generic versions of multiple sclerosis drugs, directly competing with Biogen's branded products.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca PLC has a diversified portfolio that includes new efforts in neurology and biologics, competing with Biogen's research and development focus.

About

There is no Profile data available for IDP.SG.
Show more...
CEO
Mr. Christopher A. Viehbacher
Employees
7605
Country
United States
ISIN
US09062X1037

Listings

BA
AR
BIIB.BA
MU
DE
IDP.MU
STU
DE
IDP.STU
VI
AT
BIIB.VI

0 Comments

Share your thoughts

FAQ

What is Biogen stock price today?▼
The current price of BIIB is $189.13 USD — it has increased by +1.03% in the past 24 hours. Watch Biogen stock price performance more closely on the chart.
What is Biogen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biogen stocks are traded under the ticker BIIB.
Is Biogen stock price growing?▼
BIIB stock has fallen by -2.7% compared to the previous week, the month change is a +9.74% rise, over the last year Biogen has showed a +61.9% increase.
What is Biogen market cap?▼
Today Biogen has the market capitalization of 27.76B
When is the next Biogen earnings date?▼
Biogen is going to release the next earnings report on July 16, 2026.
What were Biogen earnings last quarter?▼
BIIB earnings for the last quarter are 3.57 USD per share, whereas the estimation was 3.05 USD resulting in a +16.91% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biogen revenue for the last year?▼
Biogen revenue for the last year amounts to 19.78B USD.
What is Biogen net income for the last year?▼
BIIB net income for the last year is 2.59B USD.
How many employees does Biogen have?▼
As of May 06, 2026, the company has 7,605 employees.
In which sector is Biogen located?▼
Biogen operates in the Health & Wellness sector.
When did Biogen complete a stock split?▼
The last stock split for Biogen was on January 18, 2001 with a ratio of 3:1.
Where is Biogen headquartered?▼
Biogen is headquartered in Cambridge, United States.